Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.33 |
| ▸ | FLT1 | P17948 | 1/20 | 0.32 |
| ▸ | KDR | P35968 | 1/20 | 0.32 |
| ▸ | HTR2A | P28223 | 1/20 | 0.32 |
| ▸ | HTR2C | P28335 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18339396 | 0.78 | ALDH1A1 (0.44) | L3MBTL1HTTFLT1KDRKDM4E | |
| SCHEMBL1357879 | 0.73 | HTT (0.50) | L3MBTL1HTTSMN1; SMN2LMNAGAA | |
| SCHEMBL1431345 | 0.73 | ASPH (0.39) | L3MBTL1HTTSMN1; SMN2NTRK1FLT1 | |
| SCHEMBL31719628 | 0.70 | PPARG (0.47) | SMN1; SMN2GAA | |
| SCHEMBL1432563 | 0.70 | HTT (0.43) | L3MBTL1HTTSMN1; SMN2KDM4EGAA | |
| SCHEMBL31363015 | 0.69 | SORT1 (0.39) | L3MBTL1FLT1KDRKDM4EALDH1A1 | |
| SCHEMBL31363023 | 0.69 | HTT (0.42) | L3MBTL1HTTSMN1; SMN2LMNAHTR2A | |
| SCHEMBL1758499 | 0.68 | PKM (0.48) | L3MBTL1HTR2AHTR2C | |
| SCHEMBL68535 | 0.67 | PDE10A (0.41) | L3MBTL1HTTSMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL2212203 | 0.67 | L3MBTL1 (0.39) | L3MBTL1HTTSMN1; SMN2KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150099766-A1 | Novel halogen-substituted compounds | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150099766-A1 | Novel halogen-substituted compounds | L3MBTL4, PRDX4, PRDX1 | L3MBTL1 5/4885HTT 1096/4885SMN1; SMN2 2492/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.